Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
出版年份 2021 全文链接
标题
Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
作者
关键词
-
出版物
Translational Psychiatry
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-10
DOI
10.1038/s41398-021-01531-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metagenome-wide association of gut microbiome features for schizophrenia
- (2020) Feng Zhu et al. Nature Communications
- Composition of Gut Microbiota in Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
- (2020) Lucía Iglesias-Vázquez et al. Nutrients
- Lactobacillus plantarum DR7 Modulated Bowel Movement and Gut Microbiota Associated with Dopamine and Serotonin Pathways in Stressed Adults
- (2020) Guoxia Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Altered gut microbiota associated with symptom severity in schizophrenia
- (2020) Shijia Li et al. PeerJ
- Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study
- (2020) Rubing Pan et al. PSYCHIATRY RESEARCH
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- (2020) F. Borgo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice
- (2019) Peng Zheng et al. Science Advances
- Effects of Serotonin and Slow-release 5-HTP on Gastrointestinal Motility in a Mouse Model of Depression
- (2019) Narek Israelyan et al. GASTROENTEROLOGY
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
- (2019) Jochen Kindler et al. MOLECULAR PSYCHIATRY
- Altered gut microbiota and mucosal immunity in patients with schizophrenia
- (2019) Ruihuan Xu et al. BRAIN BEHAVIOR AND IMMUNITY
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Mapping human microbiome drug metabolism by gut bacteria and their genes
- (2019) Michael Zimmermann et al. NATURE
- Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions
- (2019) Michael I McBurney et al. JOURNAL OF NUTRITION
- Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study
- (2019) Pełka-Wysiecka et al. Journal of Clinical Medicine
- Analysis of gut mycobiota in first-episode, drug-naïve Chinese patients with schizophrenia: A pilot study
- (2019) Xue Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- Type 1 diabetes induces cognitive dysfunction in rats associated with alterations of the gut microbiome and metabolomes in serum and hippocampus
- (2019) Hongchang Gao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- An ex vivo fermentation screening platform to study drug metabolism by human gut microbiota
- (2018) Evita van de Steeg et al. DRUG METABOLISM AND DISPOSITION
- Gut microbiota in HIV-infected individuals linked to coronary heart disease
- (2018) J Kehrmann et al. JOURNAL OF INFECTIOUS DISEASES
- Extensive impact of non-antibiotic drugs on human gut bacteria
- (2018) Lisa Maier et al. NATURE
- Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects
- (2018) Tanya T. Nguyen et al. SCHIZOPHRENIA RESEARCH
- Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia
- (2018) Xiuxia Yuan et al. SCHIZOPHRENIA RESEARCH
- Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study
- (2018) Yang Shen et al. SCHIZOPHRENIA RESEARCH
- C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
- (2018) Guillaume Fond et al. Frontiers in Psychiatry
- Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells
- (2018) Huimin Hu et al. INFLAMMATION
- An improved rat model for chronic inflammatory bowel disease
- (2018) Naga K.R. Ghattamaneni et al. Pharmacological Reports
- Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder
- (2017) Ping Lin et al. JOURNAL OF AFFECTIVE DISORDERS
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- The complement system: a gateway to gene–environment interactions in schizophrenia pathogenesis
- (2017) V L Nimgaonkar et al. MOLECULAR PSYCHIATRY
- Associations between anthropometric parameters and lipid profiles in Chinese individuals with age ≥40 years and BMI
- (2017) Zhi Yang et al. PLoS One
- Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
- (2017) Igor Cervenka et al. SCIENCE
- The control of the false discovery rate in fixed sequence multiple testing
- (2017) Gavin Lynch et al. Electronic Journal of Statistics
- New evidences on the altered gut microbiota in autism spectrum disorders
- (2017) Francesco Strati et al. Microbiome
- Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
- (2017) Emanuel Schwarz et al. SCHIZOPHRENIA RESEARCH
- Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia
- (2016) Junghee Lee et al. TRENDS IN NEUROSCIENCES
- Kraepelin revisited: schizophrenia from degeneration to failed regeneration
- (2015) P Falkai et al. MOLECULAR PSYCHIATRY
- Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls
- (2015) Eduardo Castro-Nallar et al. PeerJ
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- Genomics of schizophrenia: time to consider the gut microbiome?
- (2014) T G Dinan et al. MOLECULAR PSYCHIATRY
- Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia
- (2014) A D Stan et al. MOLECULAR PSYCHIATRY
- UPARSE: highly accurate OTU sequences from microbial amplicon reads
- (2013) Robert C Edgar NATURE METHODS
- Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia
- (2013) Xueqin Song et al. PSYCHOPHARMACOLOGY
- The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
- (2012) Christian Quast et al. NUCLEIC ACIDS RESEARCH
- UCHIME improves sensitivity and speed of chimera detection
- (2011) Robert C. Edgar et al. BIOINFORMATICS
- Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
- (2011) B. J. Haas et al. GENOME RESEARCH
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
- (2010) E F Murphy et al. GUT
- Diversity of anaerobic fungal populations in cattle revealed by selective enrichment culture using different carbon sources
- (2009) G.W. Griffith et al. Fungal Ecology
- The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
- (2008) Xue-Qin Song et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started